The Australian Lawyer Who Fought for Prison Reform and Much More
The Australian Lawyer Who Fought for Prison Reform and Much More Read More »
Justin Bieber’s Penis Video
Justin Bieber’s DUI arrest in Miami, along with additional charges, was one thing. His penis video is to follow up his peeing video, which is a follow up to his push-up video which was, as TMZ announced, that Bieber’s a “hard mofo”, but now he’s also showing his badass tats, to quote TMZ again. But now a
The Big Law Firm Branding Problem (4 of them, actually)
Law firm branding has become a more important issue for law firms in a post-recession environment. But according to one branding agency, law firm branding is in regression. Why? Because for some reason brand awareness and related issues are dropping along with the quality and quantity of law firm branding. Greenfield Belser decided to poll
The Big Law Firm Branding Problem (4 of them, actually) Read More »
What to Do if You are Injured by a ZombiE
Were you a big fan of all things ZOMBIE? Did Night of the Living Dead scare your pants off when you were a kid? We’re talking the George Romero Classic, not the lackluster remakes, by the way. I’ll bet you watched so many movies and TV shows about the undead that the they began
Class Action Privacy and FCRA Defense Lawyer Joins Reed Smith from DLA Piper
March 5, 2014, Chicago, IL – Reed Smith LLP today announced that Michael O’Neil has joined the firm as a partner in its Chicago office, where he will be a member of the firm’s Global Regulatory Enforcement Group. O’Neil joins Reed Smith from DLA Piper, where he was Chair of the Privacy Litigation Group
Class Action Privacy and FCRA Defense Lawyer Joins Reed Smith from DLA Piper Read More »
Orricks Achieves Succesful en banc Federal Court Decision for Universal Lighting Technologies
UNITED STATES, March 6, 2014 – The en banc Federal Circuit Court of Appeals has given Orrick client Universal Lighting Technologies, Inc. a complete victory over its opponent, a subsidiary of Acacia Research Corporation, in a highly anticipated decision in Lighting Ballast Control LLC v. Philips Electronics N.A. Corp., No. 2012-1014 (Fed. Cir. Feb.
Clifford Chance Scoops Law Firm of the Year in Europe (Transactions) Win
LawFuel.com – Hong Kong, London: Leading international law firm Clifford Chance is pleased to announce it has been voted “Law Firm of the Year in Europe (transactions)” for the 13th consecutive year and “Law Firm of the Year in Asia (transactions)” for the 2nd consecutive year by more than 40,000 readers of Private Equity International.
Clifford Chance Scoops Law Firm of the Year in Europe (Transactions) Win Read More »
New York Attorney Names New Terrorism & Public Corruption Appointments
Preet Bharara, the United States Attorney for the Southern District of New York, announced today the appointments of Brendan McGuire as Co-Chief of the Terrorism & International Narcotics Unit and Arlo Devlin-Brown as Chief of the Public Corruption Unit. Mr. McGuire joined the U.S. Attorney’s Office in 2005. Prior to being named Co-Chief of
New York Attorney Names New Terrorism & Public Corruption Appointments Read More »
Trigger-Happy Pistorius? The Prosecution Take Aim at Oscar Pistorius
Oscar Pistorius, the “Blade Runner” defendant in the shooting of his girlfriend, appears to have had previous gun issues. A month before the para-Olympian was alleged to have killed his girlfriend he accidentally fired a gun under a table in a Johannesburg restaurant, requesting that a friend, Darren Fresco, take the blame for the discharge.
Trigger-Happy Pistorius? The Prosecution Take Aim at Oscar Pistorius Read More »
Law Firm Announces Class Action Against The Medicines Company
NEW YORK, March 4, 2014 LawFuel.com — The Rosen Law Firm, P.A. announces that a class action lawsuit has been filed on behalf of purchasers of the securities of The Medicines Company (Nasdaq:MDCO) between February 20, 2013 and February 12. 2014, inclusive (the “Class Period”) seeking remedies under the federal securities laws. To join The
Law Firm Announces Class Action Against The Medicines Company Read More »